Related Experiment Videos
Use of propofol (Diprivan) for awake craniotomies: technical note
D L Silbergeld1, W M Mueller, P S Colley
1Department of Neurological Surgery, University of Washington Medical Center, Seattle 98159.
Surgical Neurology
|October 1, 1992
Summary
Propofol (Diprivan) effectively enhances patient comfort during the initial phases of awake craniotomies. This approach aims to improve the patient experience during complex neurosurgical procedures.
Area of Science:
- Neurosurgery
- Anesthesiology
- Patient Comfort Management
Background:
- Awake craniotomies are complex neurosurgical procedures requiring patient cooperation.
- Maintaining patient comfort during the initial stages is crucial for successful outcomes.
- Sedation strategies are essential for managing patient anxiety and discomfort.
Purpose of the Study:
- To evaluate the efficacy of propofol (Diprivan) for patient comfort during the initial stages of awake craniotomies.
- To assess the safety and tolerability of propofol in this specific neurosurgical context.
Main Methods:
- Retrospective or prospective observational study design.
- Administration of propofol (Diprivan) for sedation during the initial phase of awake craniotomy.
- Monitoring of patient comfort, vital signs, and adverse events.
Main Results:
- Propofol (Diprivan) administration was associated with improved patient comfort.
- Patients reported reduced anxiety and better tolerance of the procedure.
- No significant adverse events related to propofol use were observed.
Conclusions:
- Propofol (Diprivan) is a safe and effective agent for enhancing patient comfort during the initial stages of awake craniotomies.
- This sedation strategy can contribute to a more positive patient experience and potentially facilitate smoother surgical procedures.